In bladder cancer, CBX7 inhibits the Aldo-keto reductase family 1 member B10 and subsequently stimulates Extracellular Signal-Regulated Kinase signaling, thereby suppressing bladder cancer progression [13]. This evidence concerns the gene AKR1B10 and urinary bladder cancer.